Details for Patent: 11,975,047
✉ Email this page to a colleague
Which drugs does patent 11,975,047 protect, and when does it expire?
Patent 11,975,047 protects PURIFIED CORTROPHIN GEL and is included in one NDA.
Drugs Protected by US Patent 11,975,047
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | 11,975,047 | ⤷ Subscribe | ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS | ⤷ Subscribe | ||||
| Ani Pharms | PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | 11,975,047 | ⤷ Subscribe | ALLERGIC CONJUNCTIVITIS | ⤷ Subscribe | ||||
| Ani Pharms | PURIFIED CORTROPHIN GEL | corticotropin | INJECTABLE;INJECTION | 008975-002 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | 11,975,047 | ⤷ Subscribe | ANTERIOR SEGMENT INFLAMMATION | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
